NVE Corp: Form 10-K for the period ended Mar 31, 2021
Filed with the SEC on May 5, 2021 and accepted by EDGAR at May 5, 2021, 20:21 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2020-04-01 to 2021-03-31 | $21.4m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 12 months2020-04-01 to 2021-03-31 | $4.1m | us-gaap:CostOfRevenue |
| Gross profit | 12 months2020-04-01 to 2021-03-31 | $17.2m | us-gaap:GrossProfit |
| Research and development | 12 months2020-04-01 to 2021-03-31 | $3.2m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2020-04-01 to 2021-03-31 | $1.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2020-04-01 to 2021-03-31 | $12.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2020-04-01 to 2021-03-31 | $2.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2020-04-01 to 2021-03-31 | $11.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2020-04-01 to 2021-03-31 | $2.42 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2020-04-01 to 2021-03-31 | $2.42 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2020-04-01 to 2021-03-31 | 4,834,462 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2020-04-01 to 2021-03-31 | $13.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2020-04-01 to 2021-03-31 | $62.7k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2020-04-01 to 2021-03-31 | $19.3m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2020-04-01 to 2021-03-31 | $91.4k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2021-03-31 | $10.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-03-31 | $24.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2021-03-31 | $72.5m | us-gaap:Assets |
| Current liabilities | At period end2021-03-31 | $1.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-03-31 | $1.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-03-31 | $70.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000724910-21-000008. Last ingested by Listed: Oct 24, 2026, 14:55 ET. Listed shows no prices and gives no investment advice.